事前医療の世界市場レポート2025-2031

QY Research > レポート一覧 > ソフト及び商業サービス > 事前医療の世界市場レポート2025-2031

英文タイトル： Global Advance Directives Market Outlook, In‑Depth Analysis & Forecast to 2031

レポートID：1400857
発表時期：2025-10-03
訪問回数：3
ページ数：149
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：152
レポートカテゴリ：ソフト及び商業サービス

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、事前医療の世界市場規模を概説しております。2021年から2025年までの過去の市場収益データ、2026年の予測値、ならびに2032年までの複合年間成長率（CAGR）予測を分析することにより、世界市場の動向を包括的に提示しております。報告書では事前医療の主要メーカーを詳細に分析し、各地域および国別の収益分布の特徴を明らかにしております。本報告書は特に主要地域／国家レベルにおけるセグメント市場及びサブセグメント市場に焦点を当て、将来の市場ポテンシャルの探求と予測に注力しております。多地域を網羅した包括的なデータと市場価値分析を通じて、体系的かつ深い市場洞察を得ることが可能です。
世界の事前医療市場における主要参入企業について、本報告書は以下のパラメータに基づき企業概要、収益、粗利益率、製品ポートフォリオ、地理的分布及び重要な事業展開を説明いたします：本報告書は、事前医療メーカー、地域分布、製品タイプ、エンドユーザー産業などの観点から、グローバルおよび主要地域における市場現状と発展見通しを詳細に分析しています。グローバルおよび主要地域の主要メーカーを分析し、製品タイプおよび用途/エンドユーザー産業別に事前医療市場を分類しています。

本研究の対象となる主な企業は以下の通りです：
ADvault
VyncaCare
WiserCareInc
Sharp HealthCare
ACP Decisions
lris
Healthcare
Bronson Health Care Group
Koda Health
ThroughCare
Vital Decisions
Affirm Health
MIDEO
New Century Health
Thanacare
Island Health
Honor My Decisions LLC

タイプ別の市場セグメント：
Software
Service

用途別の市場セグメント：
Child
Adult

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界の事前医療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、事前医療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、企業様に包括的な市場洞察を提供しています。レポートは、主要企業の事前医療収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界の事前医療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。また、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、事前医療市場を精密に分類・分析することで、企業が市場構造とダイナミクスをより正確に把握することを支援し、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
本レポートは、2021年から2032年までの期間について、タイプ別およびアプリケーション別の収益、成長率に基づくセグメントデータを分析します。収益、予測成長トレンド、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章節目次：
第1章：事前医療の調査範囲を明確に定義し、タイプ別分類や用途別分類などの方法により市場を細分化し、各セグメント市場の規模とその成長可能性を明らかにします（2021年～2032年）
第2章：事前医療の現在の市場状況を提示し、2032年までの世界的な収益と販売動向を予測するとともに、消費量の多い地域や新興市場の成長要因を特定します（2021年～2032年）
第3章：主要企業の状況を分析し、収益と収益性に基づくランキングを作成しつつ、製品タイプ別の企業業績、集中度、M&A動向を評価します（2021年～2032年）
第4章：事前医療の高利益率製品セグメントを解明し、収益、平均販売価格（ASP）、技術的差別化要因を比較して成長ニッチと代替リスクを明確化します（2021年～2026年）
第5章：下流市場における事前医療の機会を特定し、用途別市場規模を評価するとともに、新興ユースケースを明らかにし地域・用途別の主要顧客をプロファイリングします（2021年～2032年）
第6章：北米地域における事前医療市場を用途別・国別に分析し、主要プレイヤーをプロファイリングしつつ成長ドライバーと障壁を評価します（2021年～2032年）
第7章：欧州における事前医療市場をアプリケーション別およびプレイヤー別に分析して成長要因と障壁を明示します（2021年～2032年）
第8章：アジア太平洋地域の事前医療市場をアプリケーション別・地域/国別に定量化し、主要プレイヤーをプロファイリングするとともに高成長可能性のある地域を特定します（2021年～2032年）
第9章：中南米地域の事前医療市場をアプリケーション別・国別に測定し、主要プレイヤーをプロファイリングして投資機会と課題を明らかにします（2021年～2032年）
第10章：中東・アフリカ地域における事前医療市場をアプリケーション別・国別に評価し、主要プレイヤーをプロファイリングするとともに投資見通しと市場障壁の概要を提示します（2021年～2032年）
第11章：主要プレイヤーの詳細プロファイリングを行い、製品仕様、収益、マージンを分析し、トッププレイヤーの売上高内訳（製品タイプ別・アプリケーション別・地域別）、SWOT分析、最近の戦略的動向を整理します（2021年～2026年）
第12章：事前医療のバリューチェーンとエコシステムを分析し、上流・中流・下流チャネルの構造を明らかにします
第13章：事前医療市場の動向を探り、成長推進要因、制約要因、規制の影響、リスク軽減戦略を評価します
第14章：主要な調査結果
第15章：付録（調査方法論、市場規模の推定）

Description

The global Advance Directives market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

From a downstream perspective, Child accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Advance Directives leading manufacturers including ADvault, VyncaCare, WiserCareInc, Sharp HealthCare, ACP Decisions, lris, Healthcare, Bronson Health Care Group, Koda Health, ThroughCare, etc., dominate supply; the top five capture approximately % of global revenue, with ADvault leading 2024 sales at US$ million.

Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Advance Directives market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
ADvault
VyncaCare
WiserCareInc
Sharp HealthCare
ACP Decisions
lris
Healthcare
Bronson Health Care Group
Koda Health
ThroughCare
Vital Decisions
Affirm Health
MIDEO
New Century Health
Thanacare
Island Health
Honor My Decisions LLC

Segment by Type
Software
Service

Segment by Application
Child
Adult

Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA

Chapter Outline
Chapter 1: Defines the Advance Directives study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Advance Directives: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Advance Directives Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Service
1.3 Market Segmentation by Application
1.3.1 Global Advance Directives Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Advance Directives Revenue Estimates and Forecasts 2020-2031
2.2 Global Advance Directives Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players
3.1 Global Advance Directives Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Advance Directives Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Software Market Size by Players
3.3.2 Service Market Size by Players
3.4 Global Advance Directives Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis
4.1 Global Advance Directives Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats

5 Global Downstream Application Analysis
5.1 Global Advance Directives Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application

6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Advance Directives Market Size by Type (2020-2031)
6.4 North America Advance Directives Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Advance Directives Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico

7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Advance Directives Market Size by Type (2020-2031)
7.4 Europe Advance Directives Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Advance Directives Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia

8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Advance Directives Market Size by Type (2020-2031)
8.4 Asia-Pacific Advance Directives Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Advance Directives Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore

9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Advance Directives Market Size by Type (2020-2031)
9.4 Central and South America Advance Directives Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Advance Directives Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Advance Directives Market Size by Type (2020-2031)
10.4 Middle East and Africa Advance Directives Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Advance Directives Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa

11 Corporate Profile
11.1 ADvault
11.1.1 ADvault Corporation Information
11.1.2 ADvault Business Overview
11.1.3 ADvault Advance Directives Product Features and Attributes
11.1.4 ADvault Advance Directives Revenue and Gross Margin (2020-2025)
11.1.5 ADvault Advance Directives Revenue by Product in 2024
11.1.6 ADvault Advance Directives Revenue by Application in 2024
11.1.7 ADvault Advance Directives Revenue by Geographic Area in 2024
11.1.8 ADvault Advance Directives SWOT Analysis
11.1.9 ADvault Recent Developments
11.2 VyncaCare
11.2.1 VyncaCare Corporation Information
11.2.2 VyncaCare Business Overview
11.2.3 VyncaCare Advance Directives Product Features and Attributes
11.2.4 VyncaCare Advance Directives Revenue and Gross Margin (2020-2025)
11.2.5 VyncaCare Advance Directives Revenue by Product in 2024
11.2.6 VyncaCare Advance Directives Revenue by Application in 2024
11.2.7 VyncaCare Advance Directives Revenue by Geographic Area in 2024
11.2.8 VyncaCare Advance Directives SWOT Analysis
11.2.9 VyncaCare Recent Developments
11.3 WiserCareInc
11.3.1 WiserCareInc Corporation Information
11.3.2 WiserCareInc Business Overview
11.3.3 WiserCareInc Advance Directives Product Features and Attributes
11.3.4 WiserCareInc Advance Directives Revenue and Gross Margin (2020-2025)
11.3.5 WiserCareInc Advance Directives Revenue by Product in 2024
11.3.6 WiserCareInc Advance Directives Revenue by Application in 2024
11.3.7 WiserCareInc Advance Directives Revenue by Geographic Area in 2024
11.3.8 WiserCareInc Advance Directives SWOT Analysis
11.3.9 WiserCareInc Recent Developments
11.4 Sharp HealthCare
11.4.1 Sharp HealthCare Corporation Information
11.4.2 Sharp HealthCare Business Overview
11.4.3 Sharp HealthCare Advance Directives Product Features and Attributes
11.4.4 Sharp HealthCare Advance Directives Revenue and Gross Margin (2020-2025)
11.4.5 Sharp HealthCare Advance Directives Revenue by Product in 2024
11.4.6 Sharp HealthCare Advance Directives Revenue by Application in 2024
11.4.7 Sharp HealthCare Advance Directives Revenue by Geographic Area in 2024
11.4.8 Sharp HealthCare Advance Directives SWOT Analysis
11.4.9 Sharp HealthCare Recent Developments
11.5 ACP Decisions
11.5.1 ACP Decisions Corporation Information
11.5.2 ACP Decisions Business Overview
11.5.3 ACP Decisions Advance Directives Product Features and Attributes
11.5.4 ACP Decisions Advance Directives Revenue and Gross Margin (2020-2025)
11.5.5 ACP Decisions Advance Directives Revenue by Product in 2024
11.5.6 ACP Decisions Advance Directives Revenue by Application in 2024
11.5.7 ACP Decisions Advance Directives Revenue by Geographic Area in 2024
11.5.8 ACP Decisions Advance Directives SWOT Analysis
11.5.9 ACP Decisions Recent Developments
11.6 lris
11.6.1 lris Corporation Information
11.6.2 lris Business Overview
11.6.3 lris Advance Directives Product Features and Attributes
11.6.4 lris Advance Directives Revenue and Gross Margin (2020-2025)
11.6.5 lris Recent Developments
11.7 Healthcare
11.7.1 Healthcare Corporation Information
11.7.2 Healthcare Business Overview
11.7.3 Healthcare Advance Directives Product Features and Attributes
11.7.4 Healthcare Advance Directives Revenue and Gross Margin (2020-2025)
11.7.5 Healthcare Recent Developments
11.8 Bronson Health Care Group
11.8.1 Bronson Health Care Group Corporation Information
11.8.2 Bronson Health Care Group Business Overview
11.8.3 Bronson Health Care Group Advance Directives Product Features and Attributes
11.8.4 Bronson Health Care Group Advance Directives Revenue and Gross Margin (2020-2025)
11.8.5 Bronson Health Care Group Recent Developments
11.9 Koda Health
11.9.1 Koda Health Corporation Information
11.9.2 Koda Health Business Overview
11.9.3 Koda Health Advance Directives Product Features and Attributes
11.9.4 Koda Health Advance Directives Revenue and Gross Margin (2020-2025)
11.9.5 Koda Health Recent Developments
11.10 ThroughCare
11.10.1 ThroughCare Corporation Information
11.10.2 ThroughCare Business Overview
11.10.3 ThroughCare Advance Directives Product Features and Attributes
11.10.4 ThroughCare Advance Directives Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Vital Decisions
11.11.1 Vital Decisions Corporation Information
11.11.2 Vital Decisions Business Overview
11.11.3 Vital Decisions Advance Directives Product Features and Attributes
11.11.4 Vital Decisions Advance Directives Revenue and Gross Margin (2020-2025)
11.11.5 Vital Decisions Recent Developments
11.12 Affirm Health
11.12.1 Affirm Health Corporation Information
11.12.2 Affirm Health Business Overview
11.12.3 Affirm Health Advance Directives Product Features and Attributes
11.12.4 Affirm Health Advance Directives Revenue and Gross Margin (2020-2025)
11.12.5 Affirm Health Recent Developments
11.13 MIDEO
11.13.1 MIDEO Corporation Information
11.13.2 MIDEO Business Overview
11.13.3 MIDEO Advance Directives Product Features and Attributes
11.13.4 MIDEO Advance Directives Revenue and Gross Margin (2020-2025)
11.13.5 MIDEO Recent Developments
11.14 New Century Health
11.14.1 New Century Health Corporation Information
11.14.2 New Century Health Business Overview
11.14.3 New Century Health Advance Directives Product Features and Attributes
11.14.4 New Century Health Advance Directives Revenue and Gross Margin (2020-2025)
11.14.5 New Century Health Recent Developments
11.15 Thanacare
11.15.1 Thanacare Corporation Information
11.15.2 Thanacare Business Overview
11.15.3 Thanacare Advance Directives Product Features and Attributes
11.15.4 Thanacare Advance Directives Revenue and Gross Margin (2020-2025)
11.15.5 Thanacare Recent Developments
11.16 Island Health
11.16.1 Island Health Corporation Information
11.16.2 Island Health Business Overview
11.16.3 Island Health Advance Directives Product Features and Attributes
11.16.4 Island Health Advance Directives Revenue and Gross Margin (2020-2025)
11.16.5 Island Health Recent Developments
11.17 Honor My Decisions LLC
11.17.1 Honor My Decisions LLC Corporation Information
11.17.2 Honor My Decisions LLC Business Overview
11.17.3 Honor My Decisions LLC Advance Directives Product Features and Attributes
11.17.4 Honor My Decisions LLC Advance Directives Revenue and Gross Margin (2020-2025)
11.17.5 Honor My Decisions LLC Recent Developments

12 Advance DirectivesIndustry Chain Analysis
12.1 Advance Directives Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Advance Directives Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Advance Directives Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Advance Directives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Advance Directives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Advance Directives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Advance Directives Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Advance Directives Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Advance Directives Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Advance Directives Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Advance Directives by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advance Directives as of 2024)
 Table 11. Global Advance Directives Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Advance Directives Companies Headquarters
 Table 13. Global Advance Directives Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Advance Directives Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Advance Directives Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Advance Directives Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Advance Directives Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Advance Directives High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Advance Directives Growth Accelerators and Market Barriers
 Table 25. North America Advance Directives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Advance Directives Growth Accelerators and Market Barriers
 Table 27. Europe Advance Directives Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Advance Directives Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Advance Directives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Advance Directives Investment Opportunities and Key Challenges
 Table 31. Central and South America Advance Directives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Advance Directives Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Advance Directives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. ADvault Corporation Information
 Table 35. ADvault Description and Major Businesses
 Table 36. ADvault Product Features and Attributes
 Table 37. ADvault Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. ADvault Revenue Proportion by Product in 2024
 Table 39. ADvault Revenue Proportion by Application in 2024
 Table 40. ADvault Revenue Proportion by Geographic Area in 2024
 Table 41. ADvault Advance Directives SWOT Analysis
 Table 42. ADvault Recent Developments
 Table 43. VyncaCare Corporation Information
 Table 44. VyncaCare Description and Major Businesses
 Table 45. VyncaCare Product Features and Attributes
 Table 46. VyncaCare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. VyncaCare Revenue Proportion by Product in 2024
 Table 48. VyncaCare Revenue Proportion by Application in 2024
 Table 49. VyncaCare Revenue Proportion by Geographic Area in 2024
 Table 50. VyncaCare Advance Directives SWOT Analysis
 Table 51. VyncaCare Recent Developments
 Table 52. WiserCareInc Corporation Information
 Table 53. WiserCareInc Description and Major Businesses
 Table 54. WiserCareInc Product Features and Attributes
 Table 55. WiserCareInc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. WiserCareInc Revenue Proportion by Product in 2024
 Table 57. WiserCareInc Revenue Proportion by Application in 2024
 Table 58. WiserCareInc Revenue Proportion by Geographic Area in 2024
 Table 59. WiserCareInc Advance Directives SWOT Analysis
 Table 60. WiserCareInc Recent Developments
 Table 61. Sharp HealthCare Corporation Information
 Table 62. Sharp HealthCare Description and Major Businesses
 Table 63. Sharp HealthCare Product Features and Attributes
 Table 64. Sharp HealthCare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Sharp HealthCare Revenue Proportion by Product in 2024
 Table 66. Sharp HealthCare Revenue Proportion by Application in 2024
 Table 67. Sharp HealthCare Revenue Proportion by Geographic Area in 2024
 Table 68. Sharp HealthCare Advance Directives SWOT Analysis
 Table 69. Sharp HealthCare Recent Developments
 Table 70. ACP Decisions Corporation Information
 Table 71. ACP Decisions Description and Major Businesses
 Table 72. ACP Decisions Product Features and Attributes
 Table 73. ACP Decisions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. ACP Decisions Revenue Proportion by Product in 2024
 Table 75. ACP Decisions Revenue Proportion by Application in 2024
 Table 76. ACP Decisions Revenue Proportion by Geographic Area in 2024
 Table 77. ACP Decisions Advance Directives SWOT Analysis
 Table 78. ACP Decisions Recent Developments
 Table 79. lris Corporation Information
 Table 80. lris Description and Major Businesses
 Table 81. lris Product Features and Attributes
 Table 82. lris Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. lris Recent Developments
 Table 84. Healthcare Corporation Information
 Table 85. Healthcare Description and Major Businesses
 Table 86. Healthcare Product Features and Attributes
 Table 87. Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Healthcare Recent Developments
 Table 89. Bronson Health Care Group Corporation Information
 Table 90. Bronson Health Care Group Description and Major Businesses
 Table 91. Bronson Health Care Group Product Features and Attributes
 Table 92. Bronson Health Care Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Bronson Health Care Group Recent Developments
 Table 94. Koda Health Corporation Information
 Table 95. Koda Health Description and Major Businesses
 Table 96. Koda Health Product Features and Attributes
 Table 97. Koda Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Koda Health Recent Developments
 Table 99. ThroughCare Corporation Information
 Table 100. ThroughCare Description and Major Businesses
 Table 101. ThroughCare Product Features and Attributes
 Table 102. ThroughCare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. ThroughCare Recent Developments
 Table 104. Vital Decisions Corporation Information
 Table 105. Vital Decisions Description and Major Businesses
 Table 106. Vital Decisions Product Features and Attributes
 Table 107. Vital Decisions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Vital Decisions Recent Developments
 Table 109. Affirm Health Corporation Information
 Table 110. Affirm Health Description and Major Businesses
 Table 111. Affirm Health Product Features and Attributes
 Table 112. Affirm Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Affirm Health Recent Developments
 Table 114. MIDEO Corporation Information
 Table 115. MIDEO Description and Major Businesses
 Table 116. MIDEO Product Features and Attributes
 Table 117. MIDEO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. MIDEO Recent Developments
 Table 119. New Century Health Corporation Information
 Table 120. New Century Health Description and Major Businesses
 Table 121. New Century Health Product Features and Attributes
 Table 122. New Century Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. New Century Health Recent Developments
 Table 124. Thanacare Corporation Information
 Table 125. Thanacare Description and Major Businesses
 Table 126. Thanacare Product Features and Attributes
 Table 127. Thanacare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Thanacare Recent Developments
 Table 129. Island Health Corporation Information
 Table 130. Island Health Description and Major Businesses
 Table 131. Island Health Product Features and Attributes
 Table 132. Island Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Island Health Recent Developments
 Table 134. Honor My Decisions LLC Corporation Information
 Table 135. Honor My Decisions LLC Description and Major Businesses
 Table 136. Honor My Decisions LLC Product Features and Attributes
 Table 137. Honor My Decisions LLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Honor My Decisions LLC Recent Developments
 Table 139. Raw Materials Key Suppliers
 Table 140. Distributors List
 Table 141. Market Trends and Market Evolution
 Table 142. Market Drivers and Opportunities
 Table 143. Market Challenges, Risks, and Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Advance Directives Product Picture
 Figure 2. Global Advance Directives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Software Product Picture
 Figure 4. Service Product Picture
 Figure 5. Global Advance Directives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Child
 Figure 7. Adult
 Figure 8. Advance Directives Report Years Considered
 Figure 9. Global Advance Directives Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Advance Directives Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Advance Directives Revenue Market Share by Region (2020-2031)
 Figure 13. Global Advance Directives Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Software Revenue Market Share by Player in 2024
 Figure 16. Service Revenue Market Share by Player in 2024
 Figure 17. Global Advance Directives Revenue Market Share by Type (2020-2031)
 Figure 18. Global Advance Directives Revenue Market Share by Application (2020-2031)
 Figure 19. North America Advance Directives Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Advance Directives Revenue (US$ Million) in 2024
 Figure 21. North America Advance Directives Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Advance Directives Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Advance Directives Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Advance Directives Revenue (US$ Million) in 2024
 Figure 28. Europe Advance Directives Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Advance Directives Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 31. France Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Advance Directives Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Advance Directives Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Advance Directives Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Advance Directives Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 43. India Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Advance Directives Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Advance Directives Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Advance Directives Revenue (US$ Million) in 2024
 Figure 51. Central and South America Advance Directives Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Advance Directives Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Advance Directives Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Advance Directives Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Advance Directives Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Advance Directives Revenue (US$ Million) in 2024
 Figure 57. South America Advance Directives Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Advance Directives Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Advance Directives Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Advance Directives Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Advance Directives Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Advance Directives Revenue (2020-2025) & (US$ Million)
 Figure 63. Advance Directives Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed

以下、関連資料のご紹介